Seroprevalence of SARS-CoV-2-specific IgG antibodies in Kashmir, India, 7 months after the first reported local COVID-19 case: results of a population-based seroprevalence survey from October to November 2020.
S Muhammad Salim KhanMariya Amin QurieshiInaamul HaqSabhiya MajidJavid AhmadTaha AyubAshfaq Ahmad BhatAnjum Bashir FaziliAbdul Majeed GanaiYasmeen JanRauf-Ur-Rashid KaulZahid Ali KhanMuneer Ahmad MasoodiBeenish MushtaqFouzia NazirMuzamil NazirMalik Waseem RajaMahbooba RasoolAnjum AsmaShifana AyoubMunazza AzizArif Akbar BhatIqra Nisar ChowdriShaista IsmailMisbah Ferooz KawoosaMehvish Afzal KhanMosin Saleem KhanRafiya KousarAb Aziz LoneShahroz NabiMohammad ObaidTanzeela Bashir QaziIram SabahIshtiyaq Ahmad SumjiPublished in: BMJ open (2021)
During the first 7 months of the COVID-19 epidemic in Kashmir Valley, approximately 37% of individuals were infected. The reported number of COVID-19 cases was only a small fraction of the estimated number of infections. A more efficient surveillance system with strengthened reporting of COVID-19 cases and deaths is warranted.